CarsonAllaria Wealth Management’s Gilead Sciences GILD Stock Holding History

CarsonAllaria Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-120	Closed	-$13.5K	–	366
2025 Q1	$13.5K	Hold	120	–	–	0.01%	228
2024 Q4	$11.1K	Hold	120	–	–	0.01%	241
2024 Q3	$10.1K	Sell	120 -238	-66%	-$18.2K	0.01%	257
2024 Q2	$24.6K	Buy	358 +238	+198%	+$15.9K	0.02%	176
2024 Q1	$8.8K	Hold	120	–	–	0.01%	258
2023 Q4	$9.72K	Hold	120	–	–	0.01%	219
2023 Q3	$8.99K	Hold	120	–	–	0.01%	216
2023 Q2	$9.25K	Hold	120	–	–	0.01%	226
2023 Q1	$9.96K	Hold	120	–	–	0.01%	217
2022 Q4	$10K	Sell	120 -823	-87%	-$65.2K	0.01%	188
2022 Q3	$58K	Sell	943 -19	-2%	-$1.2K	0.05%	104
2022 Q2	$59K	Buy	962 +60	+7%	+$3.71K	0.06%	101
2022 Q1	$54K	Buy	902 +30	+3%	+$1.92K	0.05%	106
2021 Q4	$63K	Buy	+872	New	+$60.1K	0.06%	106

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CarsonAllaria Wealth Management's GILD Position: Q2 2025 in Review

CarsonAllaria Wealth Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 120 shares — an estimated $13.5K sold.

CarsonAllaria Wealth Management first reported a position in GILD in Q4 2021 and held it in 14 quarters. The position peaked at $63K in Q4 2021. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

CarsonAllaria Wealth Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
CarsonAllaria Wealth Management sold 120 Gilead Sciences shares in Q2 2025, an estimated $13.5K.
CarsonAllaria Wealth Management first reported a position in Gilead Sciences in Q4 2021 and held it in 14 quarters.
CarsonAllaria Wealth Management's Gilead Sciences position peaked at $63K in Q4 2021.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on CarsonAllaria Wealth Management's 13F filing for Q2 2025, filed 24 Jul 2025.